Detalhe da pesquisa
1.
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.
JAMA Oncol;
2019 Jan 31.
Artigo
em Inglês
| MEDLINE
| Fev 2019
| ID: mdl-30703190
Mostrar mais
Texto completo
Documentos relacionados
